The following report was received via email from the
VA National Health Physics Program (
NHPP):
Tibor Rubin VA Medical Center, Long Beach, California, which holds Permit Number 04-00689-07 under the VA master materials license, reported the discovery of a medical event to NHPP at approximately 1450 CDT, July 27, 2022.
A radium-223 dichloride (Xofigo(R)) therapy administration was performed at approximately 1115 PDT on July 27, 2022. The prescribed dosage was 211 microcuries, to be administered intravenously. Due to leakage at the IV 3-way stopcock, approximately only 160 microcuries was administered, resulting in about 75 percent of the prescribed dosage being delivered. This meets the reporting criteria of 10 CFR 35.3045 (a)(1)(i) and (a)(1)(i)(B).
The patient and the referring physician have been notified. No harm is expected to the patient.
NHPP will follow up with a written report in accordance with NRC requirements in 10 CFR 35.3045.
NHPP notified our NRC Region III Project Manager, Bryan Parker.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.